Press Releases

Caucus Members Applaud Passage of Critical Bill, Encourage Senate to Take Action

With the passage of the 21st Century Cures Bill in the U.S. House, cancer research received a major boost while critical childhood cancer provisions have passed while others were extended.

You are invited to the 7th Annual Childhood Cancer Summit: "Kids Are Unique: How We Are Facing These Challenges on the Quest for Cures". This year we are pleased to welcome Greg Simon, Executive Director of the Cancer Moonshot Taskforce in the Office of the Vice President as our keynote speaker. The Summit is open to the public.

The RACE for Children Act will encourage research into the optimization of pediatric use of a new form of cancer medicine called "molecular target therapy."

You are invited to the 6th Annual Childhood Cancer Summit: "Progress and Opportunities in the Fight Against Pediatric Cancer". This year we are pleased to welcome Dr. Lee Helman, the Acting Director of National Cancer Institute’s Center for Cancer Research, as our keynote speaker. The Summit is open to the public.

The Childhood Cancer STAR Act would improve efforts to identify and track childhood cancer incidences, improve the quality of life for childhood cancer survivors, ensure publicly accessible expanded access policies that provide hope for patients who have run out of options, and identify opportunities to expand the research of therapeutics necessary to treat the 15,780 children diagnosed with cancer in the U.S. every year.

The House passed the 21st Century Cures Act to increase funding for the National Institutes of Health (NIH) and reauthorize the Creating Hope Act which will incentivize the development of new treatments for children with rare pediatric diseases, such as cancer.

The sponsors of the Creating Hope Act applaud the approval of the first drug ever to treat high-risk neuroblastoma and call for the law to be made permanent.

The Childhood Cancer Caucus applauds Dr. Harold Varmus, the Director of the National Cancer Institute (NCI), for announcing the appointment of Dr. Greg Aune, a pediatric hematologist-oncologist from The University of Texas Health Science Center at San Antonio, to NCI's Council of Research Advocates.